West-Ward Pharmaceuticals Recalls Ondansetron in 5% Dextrose Injection And Metronidazole Injection, USP Bags Due To Possible Health Risk
Tue, 08 Jun 2010 15:10:00 -0500
West-Ward Pharmaceuticals Inc., of Eatontown, NJ, is voluntarily recalling all lots of Claris LifeSciences Inc. manufactured Ondansetron in 5% Dextrose Injection, supplied in 32mg/50mL Single-Use Plastic Bag Containers and Metronidazole Injection 500mg/100ml USP in Flexible IV Plastic Bag Containers. Claris recently received reports of the presence of floating matter and non-sterility in Ondansetron and Metronidazole. Non-sterile products administered intravenously may cause infections which could be fatal especially in patients who are immuno-compromised.
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · 10903 New Hampshire Ave MD 20993 · 800-439-1420
